UF Health Shands Hospital is a teaching hospital of the University of Florida in Gainesville, Florida. It is one of seven hospitals in the University of Florida Health system, and one of two campuses for UF's Health Science Center, the other being UF Health at Jacksonville.

During the past decade, UF Health Shands Cancer Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UF Health Shands Cancer Hospital" #1 sponsor was "University of Florida" with 10 trials, followed by "Seagen Inc." with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Celgene" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UF Health Shands Cancer Hospital" #1 collaborator was "American Cancer Society, Inc." with 2 trials as a collaborator, "UCB Pharma" with 2 trials as a collaborator, "CardioMed Device Consultants, LLC" with 1 trials as a collaborator, "Cellworks Group Inc." with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "UF Health Shands Cancer Hospital" are "Acute Myeloid Leukemia" (4 trials), "Multiple Myeloma" (4 trials), "Myelodysplastic Syndromes" (3 trials), "Acute Myelogenous Leukemia" (2 trials) and "Colorectal Neoplasms" (2 trials). Many other conditions were trialed in "UF Health Shands Cancer Hospital" in a lesser frequency.

Most popular intervention types in "UF Health Shands Cancer Hospital" are "Drug" (19 trials), "Other" (7 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "carboplatin" (2 trials), "33A" (1 trials), "AG-221" (1 trials) and "Anti-PD-1 Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "UF Health Shands Cancer Hospital" are 29 trials for "All" genders.

Currently, there are NaN active trials in "UF Health Shands Cancer Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in UF Health Shands Cancer Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in UF Health Shands Cancer Hospital, 7 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".